Industry Innovation in the Era of Artificial Intelligence

The AI Compass
1. Auflage 2025
ISBN: 978-1-032-83225-8
Verlag: Taylor & Francis Ltd

Buch, Englisch, 221 Seiten, Format (B × H): 156 mm x 234 mm

Reihe: CRC Press Women in AI Series

This book explores the multifaceted nature of AI implementation in modern business strategy, focusing on its present and future impact on various sectors. The book will spark fresh thinking and provide a driving force for global industrial innovation. Author Xiaomei Wang, Founder and CEO of PathoAI, former Global Leader of Big Data and Analytics at IBM, as well as General Manager of IBM Growth Markets Unit Big Data Centers, draws on over 20 years of experience in data analytics and AI to offer unique insights and a rich collection of compelling industry case studies.

Designed for business leaders, tech enthusiasts, and policymakers alike, this book is not just a manual for understanding AI, but a road map for harnessing its potential. By offering a blend of theoretical insight and practical guidance, this book empowers readers to embrace AI as a catalyst for innovation and sustainable growth in their respective fields.

Zielgruppe

Postgraduate and Professional Practice & Development

Autoren/Hrsg.

Wang, Xiaomei

Fachgebiete

• Wirtschaftswissenschaften Betriebswirtschaft Management
• Mathematik | Informatik EDV | Informatik Informatik Künstliche Intelligenz

Inhaltsverzeichnis

1. When Machines Gain Intelligence. 2. AI Revolution: "All That Is Solid Melts into Air". 3. Global Industry Transformations in the Age of Artificial Intelligence. 4. Riding the AI Wave to Unlock New Business Potential. 5. The Future of AI Unfolding.

Über Autor(innen)

Xiaomei Wang is Chairman of Global AI Inclusive Networks, where she champions the empowerment of future AI professionals. Her steadfast commitment to inclusivity and diversity embodies her vision for an equitable AI landscape. Leading this nonprofit organization, she merges extensive experience with a passion for cultivating a skilled AI community. As Founder and CEO of PathoAI, Xiaomei spearheads innovation in AI-driven diagnostics and pharmaceutical R&D, recently pioneering multimodal models that analyse complex medical data with remarkable accuracy, transforming healthcare outcomes.

With a distinguished 19-year career at IBM and credentials as a Certified Independent Director, Xiaomei stands as a prominent voice in the global AI dialogue. An accomplished author, her works include AI 3.0 and Understanding DB2.